Terra Alpha Investments LLC Purchases Shares of 13,367 Danaher Co. (NYSE:DHR)

Terra Alpha Investments LLC acquired a new position in Danaher Co. (NYSE:DHR) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 13,367 shares of the conglomerate’s stock, valued at approximately $3,068,000. Danaher comprises approximately 3.1% of Terra Alpha Investments LLC’s investment portfolio, making the stock its 15th largest holding.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Van Hulzen Asset Management LLC lifted its position in shares of Danaher by 1.2% during the 4th quarter. Van Hulzen Asset Management LLC now owns 76,493 shares of the conglomerate’s stock valued at $17,556,000 after acquiring an additional 909 shares during the last quarter. Sovereign Investment Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth $204,000. Corient Private Wealth LLC lifted its holdings in shares of Danaher by 0.8% during the fourth quarter. Corient Private Wealth LLC now owns 1,320,681 shares of the conglomerate’s stock valued at $302,714,000 after purchasing an additional 10,109 shares during the last quarter. Gitterman Wealth Management LLC increased its stake in Danaher by 25.6% in the 4th quarter. Gitterman Wealth Management LLC now owns 961 shares of the conglomerate’s stock worth $221,000 after purchasing an additional 196 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its holdings in Danaher by 11.9% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 84,054 shares of the conglomerate’s stock worth $19,295,000 after buying an additional 8,956 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Robert W. Baird dropped their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research report on Friday, December 13th. The Goldman Sachs Group set a $250.00 target price on Danaher in a report on Wednesday, January 15th. Citigroup lowered their price target on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. Finally, Raymond James reissued a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus target price of $277.76.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $211.09 on Monday. The company has a market cap of $150.87 billion, a price-to-earnings ratio of 39.98, a PEG ratio of 2.66 and a beta of 0.82. The business has a 50 day moving average price of $220.07 and a 200 day moving average price of $240.45. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the business earned $2.09 EPS. Research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.61%. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. Danaher’s payout ratio is currently 24.24%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.